CRT-targeted group | Lactate targeted group | P | |
---|---|---|---|
MAP (mmHg) | 70 [65–65] | 73 [64–81] | 0.6 |
CVP (mmHg) | 9 [7–12] | 10 [8–13] | 0.54 |
Cardiac Index (l/m/m2) | 2.7 [2.2–4] | 3.1 [2.5–3.9] | 0.4 |
Norepinephrine dose (mcg/kg/min) | 0.33 [0.11–0.46] | 0.21 [0.12–0.35] | 0.26 |
Lactate (mmol/L) | 2.3 [1.8–4] | 3.5 [1.8–7.3] | 0.37 |
CRT (s) | 3 [2–5] | 3 [2–5] | 0.82 |
ScvO2 (%) | 68 [66–76] | 73 [61–82] | 0.38 |
Delta pCO2(v-a) | 5 [4–8] | 5 [4–8] | 0.89 |
P(cv-a)CO2/Da-vO2 ratio | 1.58 [1.1–2] | 1.8 [1–2.7] | 0.6 |
L/P ratio | 12 [6.1–22.2] | 8.7 [4.5–12.4] | 0.22 |
StO2 (%) | 75 [70–85] | 80 [68–85] | 0.6 |
PDR-ICGa (%) | 15.6 [12–24] | 13 [6–14] | 0.1 |
MFIa | 2.5 [1.5–3] | 3 [2.7–3] | 0.09 |